Environmental distribution of Porcine Circovirus Type 2 (PCV2) in swine herds with natural infection.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 10 2019
15 10 2019
Historique:
received:
17
04
2019
accepted:
01
10
2019
entrez:
17
10
2019
pubmed:
17
10
2019
medline:
11
11
2020
Statut:
epublish
Résumé
Porcine circovirus type 2 (PCV2) is the aetiological agent of PCV2-Systemic Disease (PCV2-SD) and PCV2-Subclinical Infection (PCV2-SI). PCV2 is highly resistant to environmental conditions, being able to remain in the farm environment and thus represent a risk for infection maintenance. The aim of this study was to identify, under field conditions, the possible critical points in the environment of non-vaccinated farrow-to-weaning swine farms where PCV2 could accumulate and persist. For that, environmental samples from five swine farms with PCV2-SD or PCV2-SI were taken and analysed by qPCR, including different farm areas, farm personnel and management implements. PCV2 DNA was detected in the environment of all farms (42.9% of positive samples). Overall, the PCV2-SD herd seemed to present more positive samples and higher viral loads than the PCV2-SI herds. At individual farm level, weaning areas appeared to be the most contaminated facilities. In addition, PCV2 was found at high levels in most samples from farm workers, especially work boots, suggesting that they may play a role in within-farm transmission. In addition, PCV2 was detected in areas without animals the like warehouses, offices and farm perimeter. Therefore, this study is helpful to improve measures to reduce within-farm PCV2 dissemination.
Identifiants
pubmed: 31616055
doi: 10.1038/s41598-019-51473-6
pii: 10.1038/s41598-019-51473-6
pmc: PMC6794300
doi:
Substances chimiques
DNA, Environmental
0
DNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14816Références
Acta Vet Scand. 2010 Mar 19;52:22
pubmed: 20302632
Acta Vet Scand. 2015 Mar 12;57:14
pubmed: 25887040
PLoS One. 2013 Jun 21;8(6):e67293
pubmed: 23805306
Can J Vet Res. 2002 Oct;66(4):232-9
pubmed: 12418778
Prev Vet Med. 2007 Nov 15;82(1-2):138-50
pubmed: 17590460
Vet Microbiol. 2005 Dec 20;111(3-4):223-9
pubmed: 16289542
Virus Res. 2012 Mar;164(1-2):10-9
pubmed: 22056845
J Virol Methods. 2008 Jan;147(1):61-6
pubmed: 17889378
Can J Vet Res. 2003 May;67(2):114-20
pubmed: 12760476
J Vet Diagn Invest. 2011 Mar;23(2):233-40
pubmed: 21398441
Am J Vet Res. 2004 Jan;65(1):88-92
pubmed: 14719708
Vet Microbiol. 2009 Mar 30;135(3-4):272-82
pubmed: 19027247
Clin Vaccine Immunol. 2006 Aug;13(8):923-9
pubmed: 16893993
Vet Microbiol. 2016 May 1;187:70-74
pubmed: 27066711
Vet Microbiol. 2013 Oct 25;166(3-4):365-74
pubmed: 23867083
Anim Health Res Rev. 2005 Dec;6(2):119-42
pubmed: 16583778
Vet J. 2011 Jan;187(1):23-32
pubmed: 20211570
Prev Vet Med. 2013 Jun 1;110(2):88-102
pubmed: 23490147
Vet Microbiol. 2014 Oct 10;173(3-4):355-9
pubmed: 25183237
Can J Vet Res. 2009 Oct;73(4):298-302
pubmed: 20046632
Vet J. 2008 Sep;177(3):388-93
pubmed: 17851101
Prev Vet Med. 2010 Dec 1;97(3-4):228-36
pubmed: 20970864
J Vet Diagn Invest. 2000 Jan;12(1):3-14
pubmed: 10690769
Vet Microbiol. 2017 May;204:59-63
pubmed: 28532807
Expert Rev Vaccines. 2015 Mar;14(3):473-87
pubmed: 25400216
Vet Res. 2008 Sep-Oct;39(5):43
pubmed: 18413131
Res Vet Sci. 2007 Oct;83(2):274-8
pubmed: 17223145
Epidemiol Infect. 2012 Oct;140(10):1794-9
pubmed: 22117120
Virus Res. 2012 Mar;164(1-2):78-89
pubmed: 22178804
Transbound Emerg Dis. 2018 Apr;65(2):381-398
pubmed: 29124908
Prev Vet Med. 2018 May 1;153:42-46
pubmed: 29653733
PLoS One. 2018 Aug 27;13(8):e0203144
pubmed: 30148883